Endogenex
PrivateLast Round
Series C
Extension
Mar 25, 2026
Total Funding Raised
$190.51M
Momentum Score
25 /100
Company Overview
Endogenex is a medical technology company that has developed an innovative endoscopic procedure to help patients with type two diabetes regain control of their blood glucose levels through a specialized medical device.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Endogenex Comps
Public and private peers based on sector, stage, and business model.
Endogenex Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C Extension | Mar 25, 2026 | ||||
| Series C | Jun 13, 2024 | ||||
| Series B Extension | Oct 11, 2023 | ||||
| Series A | Feb 21, 2023 | ||||
| Series A Extension | Apr 19, 2021 | ||||
Series A | Nov 30, 2018 |
Key People
Founding team and executive leadership
Endogenex Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Longitude Capital | Series C Extension, Series A Extension, Series C, Series A |
| Arboretum Ventures | Series C Extension |
| Hatteras Venture Partners | Series C Extension, Series C |
| Orlando Health Ventures | Series C Extension, Series C |
| Santé Ventures | Series C Extension |
| Intuitive Ventures | Series C Extension, Series A, Series A Extension, Series C |
| Mayo Clinic Ventures | Series C Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 25, 2026
$50M Series C Extension round completed.
- May 5, 2025
Positive results from REGENT-1 study for type 2 diabetes presented at DDW 2025.
Endogenex Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Endogenex's valuation, stock price, and market status.
